Cerebral lesions in hematological malignancies: a case report

Nicoletta D'Ettore1, Valentina Scheggi2, Brunetto Alterini2

  • 1Division of General Cardiology, Cardiothoracovascular Department, Azienda Ospedaliero-Universitaria Careggi, University of Florence, Largo Brambilla 3, 50133, Florence, Italy. nicoletta.dettore@gmail.com.

Insights

A rare central nervous system disease, progressive multifocal leukoencephalopathy (PML), can occur in patients treated with monoclonal antibodies. This case highlights the importance of considering PML in patients with neurological symptoms and suspicious MRI findings, especially those on immunosuppressive therapy.

Area of Science:

  • Neurology
  • Infectious Diseases
  • Oncology

Background:

  • Progressive multifocal leukoencephalopathy (PML) is a rare, fatal demyelinating disease of the central nervous system.
  • Reactivation of the John Cunningham virus (JCV) causes PML.
  • Monoclonal antibody therapy is an emerging risk factor for PML.

Observation:

  • A 62-year-old man presented with right homonymous hemianopia.
  • Initial MRI and biopsy suggested relapsed lymphoma but revealed macrophages.
  • Worsening neurological symptoms prompted a second MRI, showing demyelinating lesions.

Findings:

  • Cerebrospinal fluid analysis detected high levels of John Cunningham virus DNA (over 9 million units/μL).
  • The patient received supportive care, but the outcome was poor.

Implications:

  • PML should be considered in the differential diagnosis of cerebral lesions in patients with hematologic malignancies.
  • Early suspicion and diagnosis of PML are crucial, particularly in patients on immunosuppressive or immunomodulatory drugs.
  • Multidisciplinary assessment aids in diagnosing cerebral lesions in immunocompromised patients.
Abstract

Related Concept Videos

Hemorrhagic Stroke l: Introduction01:17

Hemorrhagic Stroke l: Introduction

A hemorrhagic stroke is an acute neurological event that occurs when a weakened cerebral blood vessel ruptures, allowing blood to accumulate within or around the brain. The sudden release of blood forms a focal hematoma that increases intracranial pressure, displaces neural tissue, and can obstruct cerebrospinal fluid pathways. These effects may be compounded by intraventricular extension of the hemorrhage, cerebral edema, or compression of adjacent structures, all of which contribute to...
Hemorrhagic Stroke ll: Pathophysiology01:29

Hemorrhagic Stroke ll: Pathophysiology

A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...
Cerebral Edema ll: Pathophysiology01:22

Cerebral Edema ll: Pathophysiology

Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...